Posts

Zinc transporter has built-in self-regulating sensor

UPTON, NY — Scientists at the U.S. Department of Energy’s (DOE) Brookhaven Natio...

Black, Hispanic survivors of breast cancer have higher ...

Hispanic and non-Hispanic Black female survivors of breast cancer experience hig...

New model offers a way to speed up drug discovery

CAMBRIDGE, MA — Huge libraries of drug compounds may hold potential treatments f...

Humanigen presents promising new hematologic data from ...

–  Of the 14 participants enrolled and treated with lenzilumab plus azacitidine,...

Quantum materials: Electron spin measured for the first...

An international research team has succeeded for the first time in measuring the...

Program for underrepresented undergraduate students in ...

Alexandra Hanlon, director of the Virginia Tech Center for Biostatistics and Hea...

Interdisciplinary team receives continued support to vi...

The National Endowment for the Humanities awarded a $98,500 grant to an interdis...

WHO recommends Politecnico di Milano guidelines for the...

Milan, 9 June 2023 – The World Health Organisation presented in Baku (Azerbaijan...

Community Design Assistance Center helps create opportu...

The rundown facade of the Thomas Deen building in St. Paul, Virginia, belied the...

Ling Li leads team to see through eyes made of stone

Ling Li, associate professor in the Department of Mechanical Engineering, has be...

Targeting the Src N-Terminal regulatory element in cancer

“[…] Src is a recognized oncotarget.” Credit: 2023 Mezquita et al. “[…] Src is a...

Proof-of-Concept Program funds 12 research projects

Virginia Tech Intellectual Properties (VTIP) with LINK + LICENSE + LAUNCH’s Proo...

University of Chicago mathematician Vladimir Drinfeld w...

Vladimir Drinfeld, the Harry Pratt Judson Distinguished Service Professor of Mat...

GSK’s Adult Shot Arexvy Bags European Approval

With Arexvy, GSK has achieved the same status in Europe as it did with the desir...

Japanese drugmaker Eisai undergoing investigation for r...

Following the recent trend among Japanese firms, such as West Japan Railway, Tok...

FibroGen’s DMD drug fails phase 3 clinical trial, addin...

FibroGen continues to face challenges in its clinical endeavors, now extending i...